Annual Current Liabilities
$227.77 M
+$189.82 M+500.19%
December 31, 2023
Summary
- As of February 10, 2025, ACOR annual total current liabilities is $227.77 million, with the most recent change of +$189.82 million (+500.19%) on December 31, 2023.
- During the last 3 years, ACOR annual current liabilities has risen by +$90.52 million (+65.95%).
Performance
ACOR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$223.94 M
-$3.84 M-1.68%
March 31, 2024
Summary
- As of February 10, 2025, ACOR quarterly total current liabilities is $223.94 million, with the most recent change of -$3.84 million (-1.68%) on March 31, 2024.
- Over the past year, ACOR quarterly current liabilities has increased by +$189.20 million (+544.62%).
Performance
ACOR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ACOR Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +500.2% | +544.6% |
3 y3 years | +66.0% | +68.3% |
5 y5 years | +62.4% | +130.2% |
ACOR Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -83.3% | -1.7% | -86.4% |
5 y | 5-year | at high | -83.3% | -1.7% | -86.4% |
alltime | all time | at high | -99.9% | -1.7% | -96.9% |
Acorda Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2024 | - | $223.94 M(-1.7%) |
Dec 2023 | $227.77 M(+500.2%) | $227.77 M(+392.0%) |
Sep 2023 | - | $46.29 M(+52.4%) |
Jun 2023 | - | $30.39 M(-12.5%) |
Mar 2023 | - | $34.74 M(-8.5%) |
Dec 2022 | $37.95 M(-29.8%) | $37.95 M(-9.7%) |
Sep 2022 | - | $42.02 M(+2.2%) |
Jun 2022 | - | $41.12 M(-10.6%) |
Mar 2022 | - | $46.00 M(-14.9%) |
Dec 2021 | $54.02 M(-60.6%) | $54.02 M(-20.9%) |
Sep 2021 | - | $68.27 M(+0.9%) |
Jun 2021 | - | $67.66 M(-49.2%) |
Mar 2021 | - | $133.05 M(-3.1%) |
Dec 2020 | $137.25 M(+58.9%) | $137.25 M(-1.1%) |
Sep 2020 | - | $138.75 M(+0.4%) |
Jun 2020 | - | $138.23 M(+95.7%) |
Mar 2020 | - | $70.63 M(-18.2%) |
Dec 2019 | $86.39 M(-38.4%) | $86.39 M(-6.1%) |
Sep 2019 | - | $91.99 M(-2.1%) |
Jun 2019 | - | $93.95 M(-3.4%) |
Mar 2019 | - | $97.29 M(-30.6%) |
Dec 2018 | $140.26 M(-2.6%) | $140.26 M(+3.4%) |
Sep 2018 | - | $135.71 M(+12.3%) |
Jun 2018 | - | $120.87 M(+3.0%) |
Mar 2018 | - | $117.36 M(-18.5%) |
Dec 2017 | $143.96 M(-2.7%) | $143.96 M(+31.2%) |
Sep 2017 | - | $109.74 M(+2.4%) |
Jun 2017 | - | $107.14 M(-10.2%) |
Mar 2017 | - | $119.33 M(-19.3%) |
Dec 2016 | $147.90 M(+63.3%) | $147.90 M(+25.2%) |
Sep 2016 | - | $118.12 M(-13.2%) |
Jun 2016 | - | $136.13 M(+29.6%) |
Mar 2016 | - | $105.00 M(+15.9%) |
Dec 2015 | $90.59 M(-20.8%) | $90.59 M(-2.8%) |
Sep 2015 | - | $93.24 M(-16.5%) |
Jun 2015 | - | $111.67 M(-8.6%) |
Mar 2015 | - | $122.17 M(+6.8%) |
Dec 2014 | $114.38 M | $114.38 M(+13.3%) |
Sep 2014 | - | $100.92 M(+6.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2014 | - | $94.61 M(-0.1%) |
Mar 2014 | - | $94.70 M(-2.0%) |
Dec 2013 | $96.64 M(-2.3%) | $96.64 M(+9.5%) |
Sep 2013 | - | $88.26 M(-8.9%) |
Jun 2013 | - | $96.86 M(-0.0%) |
Mar 2013 | - | $96.86 M(-2.0%) |
Dec 2012 | $98.87 M(+13.2%) | $98.87 M(+20.5%) |
Sep 2012 | - | $82.04 M(-7.2%) |
Jun 2012 | - | $88.43 M(+7.8%) |
Mar 2012 | - | $82.06 M(-6.1%) |
Dec 2011 | $87.34 M(-7.3%) | $87.34 M(+17.3%) |
Sep 2011 | - | $74.44 M(-9.9%) |
Jun 2011 | - | $82.58 M(-6.2%) |
Mar 2011 | - | $88.07 M(-6.6%) |
Dec 2010 | $94.25 M(+29.3%) | $94.25 M(+5.4%) |
Sep 2010 | - | $89.45 M(+26.4%) |
Jun 2010 | - | $70.77 M(-20.6%) |
Mar 2010 | - | $89.16 M(+22.3%) |
Dec 2009 | $72.90 M(+33.5%) | $72.90 M(+12.3%) |
Sep 2009 | - | $64.89 M(-12.5%) |
Jun 2009 | - | $74.15 M(+46.5%) |
Mar 2009 | - | $50.63 M(-7.3%) |
Dec 2008 | $54.60 M(+39.1%) | $54.60 M(+12.7%) |
Sep 2008 | - | $48.46 M(+4.6%) |
Jun 2008 | - | $46.34 M(+2.5%) |
Mar 2008 | - | $45.20 M(+15.1%) |
Dec 2007 | $39.26 M(+0.9%) | $39.26 M(+7.1%) |
Sep 2007 | - | $36.66 M(-4.1%) |
Jun 2007 | - | $38.23 M(+32.8%) |
Mar 2007 | - | $28.78 M(-26.0%) |
Dec 2006 | $38.91 M(+8.5%) | $38.91 M(+41.8%) |
Sep 2006 | - | $27.44 M(+14.5%) |
Jun 2006 | - | $23.96 M(-9.7%) |
Mar 2006 | - | $26.55 M(-25.9%) |
Dec 2005 | $35.86 M(+125.9%) | $35.86 M(+21.2%) |
Sep 2005 | - | $29.60 M(+332.9%) |
Dec 2004 | $15.87 M(+4798.8%) | - |
Dec 2003 | $324.00 K(-88.3%) | - |
Sep 2003 | - | $6.84 M |
Jun 2003 | $2.77 M | - |
FAQ
- What is Acorda Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Acorda Therapeutics?
- What is Acorda Therapeutics annual current liabilities year-on-year change?
- What is Acorda Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly current liabilities year-on-year change?
What is Acorda Therapeutics annual total current liabilities?
The current annual current liabilities of ACOR is $227.77 M
What is the all time high annual current liabilities for Acorda Therapeutics?
Acorda Therapeutics all-time high annual total current liabilities is $227.77 M
What is Acorda Therapeutics annual current liabilities year-on-year change?
Over the past year, ACOR annual total current liabilities has changed by +$189.82 M (+500.19%)
What is Acorda Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ACOR is $223.94 M
What is the all time high quarterly current liabilities for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly total current liabilities is $227.77 M
What is Acorda Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ACOR quarterly total current liabilities has changed by +$189.20 M (+544.62%)